In the field of business administration, effective strategies and network building for drug discovery and medical device development have been analyzed from the perspective of pharmaceutical companies. However, the efficiency of new drug development is on the decline, and pharmaceutical companies are abandoning their self-supporting business models, and there is a growing trend toward industry-academia collaboration and open innovation, seeking drug seeds from a wide range of external sources, including academia. There is little accumulated research on the management of drug discovery and medical device development conducted by academia from a management perspective. We are conducting research on industry-academia collaboration and open innovation in drug discovery and medical device development, in which academia plays a leading role.